Tac-MMF Versus CsA-MMF/CsA-AZA-Based Regimens in Development of De Novo Complement-Binding Anti-HLA Antibodies After Kidney Transplantation

Sahutoglu T., Akgul S., Caliskan Y. K., Yazici H., Demir E., Kara E., ...More

TRANSPLANTATION PROCEEDINGS, vol.49, no.3, pp.454-459, 2017 (SCI-Expanded) identifier identifier identifier


Background. Immunosuppressive regimens with tacrolimus or cyclosporine A (CsA) were compared for graft-related outcomes in conjunction with complement-binding de novo donor-specific antibodies (DSAs).